2016 International Congress

Thursday, June 23, 2016

12:00pm-1:30pm

Syndrome of dystonia-parkinsonism is a complication of cyclosporine A treatment and may be irreversible

P. Miklavcic, S. Avcin, J. Jazbec, T. Vipotnik Vesnaver, B. Todorova, M. Trost, M. Kojovic (Ljubljana, Slovenia)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Synergistic effects of physical therapy and botulinum toxin in primary cervical dystonia

W. Hu, V. Rundle-Gonzalez, S.J. Kulkarni, L. Almeida, M. Okun, A. Wagle Shukla (Gainesville, FL, USA)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Systematic literature review of quetiapine for hallucinosis / psychosis in Parkinson’s disease (PD)

K. Dashtipour, J.J. Chen, L. Massihi, S. Tashiro, K. Frei (Loma Linda, CA, USA)

Clinical trials and therapy in movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Systems biological approach to Parkinson’s disease- Uncovering effects of PD on the synapse

K.F. Heil, O. Sorokina, J.D. Armstrong, J. Hellgren Kotaleski (Edinburgh, United Kingdom)

Other  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Taking specialist clinics into community nursing homes

T. Williams, S. Mahon, C. Thomas, B. Mohamed (Cardiff, United Kingdom)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Targeting PDE7 by the small molecule S14: A potential disease-modifying Parkinson�s disease therapy ready to start clinical trials

A. Martinez, C. Gil, D. Lopez Ribas, E. Cunchillos, J. Domenech, M. Sarasa (Madrid, Spain)

Neuropharmacology  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Tear fluid as potential biomarker for the diagnosis of Parkinson’s disease

M. Börger, S. Funke, F. Maaß, A. Fischbach, M. Bähr, F. Grus, P. Lingor (Göttingen, Germany)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Telemedicine facilitates efficient and safe home titration of levodopa/carbidopa intestinal gel (LCIG) in patients with advanced Parkinson’s disease

T. Willows, N. Dizdar, D. Nyholm, H. Widner, P. Grenholm, U. Schmiauke, A. Urbom, K. Groth, J. Larsson, J. Permert, S. Kjellander (Huddinge, Sweden)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Temporal discrimination threshold and the menstrual cycle

E.M. Mc Govern, E. O'Connor, I. Beiser, L. Williams, J.S. Butler, B. Quinlivan, R. Reilly, S. O'Riordan, M. Hutchinson (Dublin, Ireland)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Temporal dynamics of pallidal low-frequency oscillations in dystonia

D.A.I. Pina-Fuentes, J.C. van Zijl, J.W. Elting, G. Drost, J.M. van Dijk, M.A. Tijssen, M. Beudel (Groningen, Netherlands)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2